Recent advances of carbon dots as new antimicrobial agents

P Li, L Sun, S Xue, D Qu, L An, X Wang, Z Sun - SmartMat, 2022 - Wiley Online Library
Due to the COVID‐19 pandemic, many rapid antimicrobial agents have developed
intensively. Carbon dots (CDs), a new type of carbon‐based nanomaterials, shows great …

Three-dimensional in vitro cell culture models for efficient drug discovery: Progress so far and future prospects

SM Badr-Eldin, HM Aldawsari, S Kotta, PK Deb… - Pharmaceuticals, 2022 - mdpi.com
Despite tremendous advancements in technologies and resources, drug discovery still
remains a tedious and expensive process. Though most cells are cultured using 2D …

[HTML][HTML] In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19

DM Teli, MB Shah, MT Chhabria - Frontiers in molecular biosciences, 2021 - frontiersin.org
Historically, plants have been sought after as bio-factories for the production of diverse
chemical compounds that offer a multitude of possibilities to cure diseases. To combat the …

Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing

AA El-Malah, MM Gineinah, PK Deb, AN Khayyat… - Pharmaceuticals, 2022 - mdpi.com
The introduction of selective COX-2 inhibitors (so-called 'coxibs') has demonstrated
tremendous commercial success due to their claimed lower potential of serious …

[HTML][HTML] Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients …

P Borah, PK Deb, B Chandrasekaran… - Frontiers in molecular …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-
converting enzyme 2 (ACE2) receptor and invade the human cells to cause COVID-19 …

[HTML][HTML] Exploring the potential of carbon dots to combat COVID-19

S Kotta, HM Aldawsari, SM Badr-Eldin… - Frontiers in Molecular …, 2020 - frontiersin.org
Viral diseases are considered as a global burden. The eradication of viral diseases is
always a challenging task in medical research due to the high infectivity and mutation …

Quantifying the COVID‐19 endgame: Is a new normal within reach?

H Rahmandad, J Sterman - System dynamics review, 2022 - Wiley Online Library
Eradication of COVID‐19 is out of reach. Are we close to a “new normal” in which people
can leave behind restrictive non‐pharmaceutical interventions (NPIs) yet face a tolerable …

[HTML][HTML] Perspectives on RNA vaccine candidates for COVID-19

P Borah, PK Deb, NA Al-Shar'i… - Frontiers in Molecular …, 2021 - frontiersin.org
With the current outbreak caused by SARS-CoV-2, vaccination is acclaimed as a public
health care priority. Rapid genetic sequencing of SARS-CoV-2 has triggered the scientific …

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

G Joshi, P Borah, S Thakur, P Sharma… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT As of September 2021, 117 COVID-19 vaccines are in clinical development,
and 194 are in preclinical development as per the World Health Organization (WHO) …

[HTML][HTML] SARS CoV-2 organotropism associated pathogenic relationship of gut-brain axis and illness

P Shinu, MA Morsy, PK Deb, AB Nair… - Frontiers in molecular …, 2020 - frontiersin.org
COVID-19 has resulted in a pandemic after its first appearance in a pneumonia patient in
China in early December 2019. As per WHO, this global outbreak of novel COVID-19 has …